Profile: Ardana Plc (ARA.L)

Ardana plc is a pharmaceutical company. The Company is focused on the discovery, development and marketing of products to improve human reproductive health. Its principal products include Emselex, a once a day treatment for the symptoms of overactive bladder syndrome; Striant SR, a testosterone replacement therapy for men with confirmed hypogonadism; Invicorp, an injectable combination drug treatment for erectile dysfunction; Testosterone Cream, a trans-dermal testosterone delivery system in development for the treatment of male hypogonadism, in Phase III trails; GHS, a growth hormone secretagogue in late-stage development for the diagnosis of growth hormone deficiency, and Teverelix LA, in development for three initial indications (prostate cancer, benign prostatic hyperplasia and endometriosis). The Company’s operations are located in the United Kingdom, with commercialization and development activities being carried out in the United Kingdom and the rest of Europe.